Stallion Labs




Concise Prescribing Info
Per 1 mL L-leucine 10.3 mg, L-lysine (as HCl) 7.1 mg, L-alanine 6.3 mg, L-valine 6.2 mg, L-isoleucine 5.1 mg, L-arginine 4.9 mg, L-threonine 4.8 mg, L-serine 4.5 mg, L-histidine 4.3 mg, L-proline 4.3 mg, L-phenylalanine 3.8 mg, L-glycine 3.2 mg, L-methionine 2.8 mg, L-tryptophan 1.9 mg, L-cysteine (as acetyl) 370 mcg
Supply of amino acids in acute & chronic renal insufficiency, hemofiltration, peritoneal & hemodialysis.
Dosage/Direction for Use
Max: 1 g amino acids/kg/day. Acute & chronic renal insufficiency not treated by dialysis Max: 1.5 g amino acids/kg/day. Acute & chronic renal insufficiency treated by hemofiltration, peritoneal & hemodialysis Max: 0.5 g amino acids/kg/day. Childn Should not exceed twice normal serum osmolarity (718 mOsmol/L).
Hepatic coma or metabolic disorders involving impaired nitrogen utilization. Disturbances of the amino acid metabolism. Hepatic coma, serious renal disturbances, hyponatremia, hyperkalemia, congestive cardiac failure, hyperhydration, metabolic acidosis, liver failure.
Special Precautions
May cause allergic-type reactions due to Na metabisulfite content. Frequent evaluation & lab determinations for proper monitoring of parenteral nutrition. GI bleeding; azotemia. Discontinue use if symptoms of hyperammonemia develop; venous thrombosis or phlebitis occurs. Administration of IV soln; strongly hypertonic nutrient soln; glucose; w/ hypertonic dextrose in diabetic or prediabetic patient. Monitor changes in fluid balance, electrolyte conc & acid-base balance during prolonged parenteral therapy. Patients w/ cardiac insufficiency. Always be accompanied by dextrose when infusing in patients w/ MI. Extraordinary electrolyte losses during protracted nasogastric suction, vomiting, diarrhea or GI fistula drainage. Metabolic acidosis, hypophosphatemia, hypocalcemia. Renal & hepatic impairment. Pregnancy. Childn. Elderly.
Adverse Reactions
Wt gain, edema, increased BUN & mild acidosis. Febrile response, infection at site of inj, venous thrombosis or phlebitis extending from site of inj, extravasation & hypervolemia. Warm sensation, erythema, phlebitis & thrombosis. Nausea, chills, vomiting (rapid infusion rate).
Drug Interactions
Decreased absorption & effectiveness of levodopa; medications for diabetes eg, glimepiride, glyburide, insulin, pioglitazone, rosiglitazone, chlorpropamide, glipizide, tolbutamide. Decreased effects w/ diazoxide, glucocorticoids. Decreased break-down w/ thyroid hormones.
ATC Classification
V06DD - Amino acids, incl. combinations with polypeptides ; Used as general nutrients.
Stalmino soln for IV infusion 70 mg/mL
500 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in